Paras Healthcare Schedules Board Meeting to Approve Q2 and H1'27 Results
Paras Healthcare Limited 路 Intimation 路 05 Nov 2026, 5:30 am
Paras Healthcare Schedules Board Meeting to Approve Q2 and H1'27 Results Paras Healthcare Limited has scheduled a meeting of its Board of Directors on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed for designated persons and their immediate relatives from 28th Oct'26 and will remain shut until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Paras Healthcare Limited
- Transcript of the Earnings Conference Call held to discuss the Financial Results of the Company for the Quarter and half year ended September 30, 2026 路 13 Nov 2026
- Schedule of Investor Meet under Regulation 30 of SEBI Listing Regulations 路 12 Nov 2026
- Audio Recording of Earnings Call on Financial Results of the Company for the Quarter and Half Year ended September 30, 2026 路 07 Nov 2026
- Investor Presentation on Financial Results of the Company for the Quarter and Half Year Ended September 30, 2026 路 06 Nov 2026
- Disclosure under Regulation 30 of Listing Regulation 路 06 Nov 2026
- Paras Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company. 路 06 Nov 2026
- Press Release - Paras Health Reports robust revenue growth of 23% in Q2 YoY to Rs. 511 Cr. ; EBITDA up 43% YoY; PAT up 3.3x YoY 路 06 Nov 2026
- Board Approved Unaudited Financials Results for Quarter and Half Year ended September 30, 2026 路 06 Nov 2026
